Rectiv(Nitroglycerin)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$2.2M
Medicare cost, 2024
$2.2M
Medicare cost, 2024
Medicare drug plans spent $2.2 million on Rectiv (nitroglycerin) in 2024, for 3,206 prescriptions and refills filled by 1,834 patients. Spending fell 63% from 2023 to 2024. New York accounts for the most spending ($479,433, 22% of the total).
Medicare cost, 2024
$2.2M
-63.0% from 2023
Prescriptions
3,206
$671.17 per claim
Patients
1,834
1,699 prescribers
Total spending, 2024
$2.2M
$1,176.84 per patient
Questions and answers
How much does Medicare spend on Rectiv?
Medicare prescription drug plans paid $2.2M for Rectiv in 2024, for 3,206 prescriptions and refills to 1,834 patients (down 63.0% from 2023). The average cost per claim was $671.17.
Which state spends the most on Rectiv?
New York had the highest Medicare cost for Rectiv in 2024: $479K for 740 claims, followed by New Jersey ($233K).
Who prescribes Rectiv the most?
Sixto R Caro, internal medicine in Brooklyn, NY, had the highest Medicare cost for Rectiv in 2024: 39 claims costing $32K.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Rectiv was $2.2M in 2024, after a high of $5.8M in 2023.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Rectiv, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sixto R Caro Brooklyn, NY | Internal Medicine | 39 | Under 11 | $32K |
| 1699742932 | Internal Medicine | 50 | Under 11 | $29K |
| Ghias Moussa Jersey City, NJ | Cardiology | 30 | Under 11 | $26K |
| Housein M Wazaz Meriden, CT | Gastroenterology | 38 | 20 | $25K |
| Mara Khaylomskaya New York, NY | Internal Medicine | 40 | Under 11 | $24K |
| Valerija Shvartsman Bronx, NY | Nurse Practitioner | 35 | Under 11 | $21K |
| Alexander Shekhter Brooklyn, NY | Internal Medicine | 22 | Under 11 | $20K |
| Alaa S Eldin Jersey City, NJ | Gastroenterology | 12 | Under 11 | $18K |
| Ahab Gabriel East Brunswick, NJ | Internal Medicine | 28 | Under 11 | $16K |
| Konstantin Peysin Brooklyn, NY | Internal Medicine | 23 | Under 11 | $14K |
| Heather L Rossi Coon Rapids, MN | Colorectal Surgery (Proctology) | 19 | 11 | $12K |
| Zinovy N Lekht Sun Valley, CA | Internal Medicine | 17 | Under 11 | $11K |
| Oleksandr Seleverstov College Place, WA | Internal Medicine | 12 | Under 11 | $11K |
| Michael Nemirovsky Utica, NY | Family Practice | 12 | Under 11 | $10K |
| Anatole Barkan Brooklyn, NY | Internal Medicine | 17 | Under 11 | $10K |
| Jee Hoon Jang Simi Valley, CA | Internal Medicine | 16 | Under 11 | $10K |
| Khalil Innabi Yonkers, NY | Family Practice | 12 | Under 11 | $9,352 |
| Jacob V George Brooklyn, NY | Internal Medicine | 12 | Under 11 | $8,994 |
| Scott Suchin Bronx, NY | Gastroenterology | 15 | Under 11 | $8,994 |
| Aleksandr Zasypkin Brooklyn, NY | Internal Medicine | 13 | Under 11 | $8,155 |
| Nirish S Shah Roanoke, VA | Gastroenterology | 13 | Under 11 | $8,011 |
| Murali M Alloju Frisco, TX | Gastroenterology | 13 | Under 11 | $8,003 |
| Aria Behrouzi Christiansburg, VA | Family Practice | 11 | Under 11 | $8,001 |
| Sujithraj Dommaraju Ithaca, NY | Internal Medicine | 12 | Under 11 | $7,961 |
| Jennifer L Geremia Cranston, RI | Physician Assistant | 13 | Under 11 | $7,795 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 3,951 | 7,158 | 4,409 | $5.2M |
| 2023 | 4,532 | 8,159 | 5,040 | $5.8M |
| 2024 | 1,699 | 3,206 | 1,834 | $2.2M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Aptalis/Allerga | 3,218 | $2.2M |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 1
- RxNorm concept IDs
- 1114466, 1114470
- Application numbers
- NDA021359
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 54,581 side-effect reports named nitroglycerin, the active ingredient of Rectiv (reports from 1999 on). 43,046 of them (78.9%) were serious, 7,098 named a death and 24,710 named a hospital stay. The reactions named most often were dyspnoea, pain and fatigue. 15,039 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
54,581
3,130 in 2025 (-2.5% from 2024)
Serious
78.9%
43,046 reports
Deaths named
7,098
13.0% of reports
Hospital stays
24,710
45.3% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
Since 2002. 2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Rectiv?
54,581 reports from 1999 through September 2026 named nitroglycerin, the active ingredient of Rectiv. 43,046 of them (78.9%) were serious, 7,098 named a death and 24,710 named a hospital stay.
What are the most reported side effects of Rectiv?
4,369 reports named dyspnoea, the reaction named most often, followed by pain (3,763) and fatigue (3,711). In the last 5 years the reaction named most often was dyspnoea (1,433 reports). A report can name several reactions.
How many side-effect reports named Rectiv in 2025?
3,130 reports were received in 2025 (-2.5% from 2024). 2026 so far: 2,060 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Rectiv caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Rectiv caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with nitroglycerin: Nitroglycerin, Nitroglycerin Patch, Nitro-Dur, Nitro-Bid, Nitrostat, Nitrolingual, Nitroglycerin*
- Makers on the stock market:
SDZ.SW·SDZ.SW drug pipeline - Drug approvals (20 approvals on file for nitroglycerin) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (nitroglycerin) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.